|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/21 | |
| A61K 39/00 |
| (11) | Patento numeris | 2981281 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13880736.7 |
| Europos patento paraiškos padavimo data | 2013-12-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-02-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/075201 |
| Data | 2013-12-14 |
| (87) | Numeris | WO 2014/163684 |
| Data | 2014-10-09 |
| (30) | Numeris | Data | Šalis |
| 201361807998 P | 2013-04-03 | US | |
| 201313966450 | 2013-08-14 | US |
| (72) |
CHANG, Chien-Hsing, US
GOLDENBERG, David, M., US
ROSSI, Edmund, A., US
ROSSI, Diane, US
|
| (73) |
IBC Pharmaceuticals, Inc.,
300 American Road, Morris Plains, NJ 07950,
US
|
| (54) | COMBINATION THERAPY FOR INDUCING IMMUNE RESPONSE TO DISEASE |
| COMBINATION THERAPY FOR INDUCING IMMUNE RESPONSE TO DISEASE |